
    
      Particulate matter(PM) exposure has been shown to increase the morbidity and mobility of a
      variety of respiratory diseases, including COPD and asthma. This study focus on the effects
      of PM on the pulmonary function and acute exacerbation of COPD and asthma patients in China,
      where PM exposure is much heavier than the United States and European countries. This study
      is an observational study which lasts 3 years. Primary outcome measures:Change in spirometry
      (FEV1) of COPD, asthma patients and healthy volunteers in response to different exposure
      doses of PM.
    
  